OpenAlex
PricingAboutJobs
Log inGet started
Work

Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)

HTML

Year: 2021
Type: review
Source: Pharmacological Research
DOI: 10.1016/j.phrs.2021.105422
Author: Robert Roskoski
Language: English

Topic: Protein Kinase Regulation and GTPase Signaling
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: covalent inhibitors, protein kinase inhibitors, Michael addition, cysteine thiolate, ibrutinib, Bruton's tyrosine kinase, acalabrutinib, zanubrutinib, afatinib, dacomitinib, osimertinib, neratinib, epidermal growth factor receptor, non-small cell lung cancer, HER2-positive breast cancer, mantle cell lymphoma, FDA-approved drugs
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3120861427
FWCI: 1.697
Cites: 125
Cited by: 94
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security